1. Home
  2. SLNO vs HIW Comparison

SLNO vs HIW Comparison

Compare SLNO & HIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • HIW
  • Stock Information
  • Founded
  • SLNO 1999
  • HIW 1978
  • Country
  • SLNO United States
  • HIW United States
  • Employees
  • SLNO N/A
  • HIW N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HIW Real Estate Investment Trusts
  • Sector
  • SLNO Health Care
  • HIW Real Estate
  • Exchange
  • SLNO Nasdaq
  • HIW Nasdaq
  • Market Cap
  • SLNO 3.8B
  • HIW 3.4B
  • IPO Year
  • SLNO 2014
  • HIW 1994
  • Fundamental
  • Price
  • SLNO $82.27
  • HIW $31.54
  • Analyst Decision
  • SLNO Strong Buy
  • HIW Buy
  • Analyst Count
  • SLNO 9
  • HIW 6
  • Target Price
  • SLNO $105.11
  • HIW $31.83
  • AVG Volume (30 Days)
  • SLNO 1.4M
  • HIW 897.2K
  • Earning Date
  • SLNO 08-06-2025
  • HIW 07-29-2025
  • Dividend Yield
  • SLNO N/A
  • HIW 6.36%
  • EPS Growth
  • SLNO N/A
  • HIW 32.01
  • EPS
  • SLNO N/A
  • HIW 1.60
  • Revenue
  • SLNO N/A
  • HIW $819,789,000.00
  • Revenue This Year
  • SLNO N/A
  • HIW $0.19
  • Revenue Next Year
  • SLNO N/A
  • HIW $5.14
  • P/E Ratio
  • SLNO N/A
  • HIW $19.60
  • Revenue Growth
  • SLNO N/A
  • HIW N/A
  • 52 Week Low
  • SLNO $41.50
  • HIW $24.19
  • 52 Week High
  • SLNO $90.32
  • HIW $36.78
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 51.33
  • HIW 57.45
  • Support Level
  • SLNO $79.70
  • HIW $30.66
  • Resistance Level
  • SLNO $90.32
  • HIW $31.65
  • Average True Range (ATR)
  • SLNO 3.66
  • HIW 0.67
  • MACD
  • SLNO -0.41
  • HIW -0.07
  • Stochastic Oscillator
  • SLNO 31.42
  • HIW 73.25

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a real estate investment trust engaged in the acquisition, ownership, management, and leasing of properties in urban areas throughout the Southern United States. In terms of total square footage, the vast majority of the company's real estate portfolio comprises office buildings in terms. Highwoods Properties derives nearly all of its income in the form of rental revenue from the tenants of its buildings. The majority of this revenue comes from its holdings in the urban markets of Atlanta, Raleigh, Nashville, and Tampa. These cities also account for the majority of the square footage under the company's ownership. Highwoods Properties customers include the U.S. Government, financial services firms, industrial supply retailers, and healthcare companies.

Share on Social Networks: